Companies : Page 39
March 20, 2024
The City of Chicago announced a first-of-its-kind lawsuit against Glock, the manufacturer of the most popular handguns in the United States, alleging that Glock is facilitating the proliferation of illegal machine guns on the streets of Chicago.
March 20, 2024
Recently, in partnership with Solartech, Astronergy delivered high efficiency module products to support two utility-scale PV farm projects in Augstynka and Jeziorko, Poland.
March 20, 2024
Zimbabwe\'s leading platinum miner, Zimplats Private, has launched a voluntary staff retrenchment program to cut costs in light of weak platinum group metals (PGM) prices.
March 20, 2024
With the delivery of the 137th train, the ICE 4 fleet of Deutsche Bahn (DB) is now complete.
March 20, 2024
The European Commission has sent a Statement of Objections to Kingspan alleging that the company provided incorrect, incomplete and misleading information during the 2021 Commission\'s investigation under the EU Merger Regulation (‘EUMR\') of Kingspan\'s planned acquisition of Trimo.
March 20, 2024
Vermont has joined the Federal Trade Commission (FTC) and its state partners in the lawsuit against Amazon.
March 20, 2024
Trina Solar announces the commencement of the groundbreaking Springbok project in collaboration with SOLA and WBHO, marking a significant milestone in South Africa\'s renewable energy landscape.
March 20, 2024
Fennec Pharmaceuticals and Norgine announced an exclusive licensing agreement under which Norgine will commercialize PEDMARQSI in Europe, Australia and New Zealand.
March 19, 2024
AstraZeneca has entered into a definitive agreement to acquire Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing next-generation radioconjugates (RCs).
March 19, 2024
SCHOTT Pharma USA, Inc. will establish a new production facility in Wilson County, creating 401 jobs, Governor Roy Cooper announced.
March 19, 2024
FINRA has fined M1 Finance $850,000 for social media posts made by influencers on the firm’s behalf that were not fair or balanced, or contained exaggerated, unwarranted, promissory or misleading claims.
March 19, 2024
clinical trial supply company Myonex has entered into agreement to acquire the clinical, commercial packaging, and bioservices business of Creapharm.